<!doctype html public "-//IETF//DTD HTML//EN">
<html>

<!-- Mirrored from informationr.net/ir/4-2/paper52.html by HTTrack Website Copier/3.x [XR&CO'2010], Sat, 25 Dec 2010 19:19:22 GMT -->
<head>
<link rel="stylesheet" href="../IRstyle.css">
<title>Information contracting <span>tools</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in a cancer specialist unit:the role of Healthcare Resource Groups (HRGs)</title>

<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="keywords" content="management information, contracting, national health service, NHS, computing, clinical requirements, financial requirements, patient-centred, <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of care,Healthcare Resource Groups, HRG, chronic care, cancer, Health Benefit Groups">
<meta name="<span>description</span>" <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> content="The need for high <span>quality</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>management information within the contracting process has driven many of the <span>major</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>developments in health service computing. These have often merged clinical and financial requirements, usually along patient-centred <span>lines</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> In order to identify a common currency for a <span>range</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of clinical activities that are inherently variable, price tariffs have been <span>drawn</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>up on the basis of 'episodes of care' within specialties. Healthcare Resource Groups (HRGs) were <span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to meet the need for a common information currency. However, they were <span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>for acute care. The study on which this paper is based aims to examine their applicability to chronic care in a cancer specialist unit. The data were <span>drawn</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the patient information system within a <span>major</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>cancer unit. The <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of the <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>is encapsulated in the following questions: a) Do HRGs really work as a grouping and costing methodology? b) How relevant are HRG classifications for long-term patient care? The <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>demonstrated that not all HRGs are iso-resource within this <span>environment</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> The <span>findings</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the data analysis are echoed by the NHS Executive's own evaluation . This does not negate advantages in their use. <span>Furthermore</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> the development of Health Benefit Groups as information management <span>tools</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> through a <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on health conditions and interventions rather than on <span>purely</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on <span>treatments</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> <span>offers</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>potential for greater validity within a chronic care <span>situation</span>. <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>">
<meta name="VW96.objecttype" content="Document">
<meta name="ROBOTS" content="ALL">
<meta name="DC.Title" content="Information contracting <span>tools</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in a cancer specialist unit:the role of Healthcare Resource Groups (HRGs)">
<meta name="DC.Creator" content="Carol Marlow, Hugh Preston">
<meta name="DC.Subject" content="management information, contracting, national health service, NHS, computing, clinical requirements, financial requirements, patient-centred, <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of care,Healthcare Resource Groups, HRG, chronic care, cancer, Health Benefit Groups">
<meta name="DC.Description" content="The need for high <span>quality</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>management information within the contracting process has driven many of the <span>major</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>developments in health service computing. These have often merged clinical and financial requirements, usually along patient-centred <span>lines</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> In order to identify a common currency for a <span>range</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of clinical activities that are inherently variable, price tariffs have been <span>drawn</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>up on the basis of 'episodes of care' within specialties. Healthcare Resource Groups (HRGs) were <span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to meet the need for a common information currency. However, they were <span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>for acute care. The study on which this paper is based aims to examine their applicability to chronic care in a cancer specialist unit. The data were <span>drawn</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the patient information system within a <span>major</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>cancer unit. The <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of the <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>is encapsulated in the following questions: a) Do HRGs really work as a grouping and costing methodology? b) How relevant are HRG classifications for long-term patient care? The <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>demonstrated that not all HRGs are iso-resource within this <span>environment</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> The <span>findings</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the data analysis are echoed by the NHS Executive's own evaluation . This does not negate advantages in their use. <span>Furthermore</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> the development of Health Benefit Groups as information management <span>tools</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> through a <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on health conditions and interventions rather than on <span>purely</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on <span>treatments</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> <span>offers</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>potential for greater validity within a chronic care <span>situation</span>. <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>">
<meta name="DC.Publisher" content="<span>Professor</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>T.D. Wilson">
<meta name="DC.Coverage.PlaceName" content="Global">
<script language="<span>JavaScript</span>" <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> type="text/JavaScript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.<span>length</span>, <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_nbGroup(event, grpName) { //v6.0
  var i,img,nbArr,args=MM_nbGroup.arguments;
  if (event == "init" && args.<span>length</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>> 2) {
    if ((img = MM_findObj(args[2])) != null && !img.MM_init) {
      img.MM_init = true; img.MM_up = args[3]; img.MM_dn = img.src;
      if ((nbArr = document[grpName]) == null) nbArr = document[grpName] = new Array();
      nbArr[nbArr.length] = img;
      for (i=4; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) {
        if (!img.MM_up) img.MM_up = img.src;
        img.src = img.MM_dn = args[i+1];
        nbArr[nbArr.length] = img;
    } }
  } else if (event == "over") {
    document.MM_nbOver = nbArr = new Array();
    for (i=1; i < args.length-1; i+=3) if ((img = MM_findObj(args[i])) != null) {
      if (!img.MM_up) img.MM_up = img.src;
      img.src = (img.MM_dn && args[i+2]) ? args[i+2] : ((args[i+1])? args[i+1] : img.MM_up);
      nbArr[nbArr.length] = img;
    }
  } else if (event == "out" ) {
    for (i=0; i < document.MM_nbOver.length; i++) {
      img = document.MM_nbOver[i]; img.src = (img.MM_dn) ? img.MM_dn : img.MM_up; }
  } else if (event == "down") {
    nbArr = document[grpName];
    if (nbArr)
      for (i=0; i < nbArr.length; i++) { img=nbArr[i]; img.src = img.MM_up; img.MM_dn = 0; }
    document[grpName] = nbArr = new Array();
    for (i=2; i < args.length-1; i+=2) if ((img = MM_findObj(args[i])) != null) {
      if (!img.MM_up) img.MM_up = img.src;
      img.src = img.MM_dn = (args[i+1])? args[i+1] : img.MM_up;
      nbArr[nbArr.length] = img;
  } }
}
//-->
</script>
<link href="http://localhost/TEXTY/css/parser.css" rel="stylesheet" type="text/css" /></head>
<body bgcolor="#ffffff" onLoad="MM_preloadImages('../figs/iauthori1.gif','../figs/isubji1.gif','../figs/isearch1.gif','../figs/ihome1.gif','../figs/contents1.gif')">
<table align="center" border="0" cellpadding="0" cellspacing="0">
<tr><td height="30" align="center" colspan="5"><h4>Information Research, Vol. 4  No. 2, October 1998</h4></td></tr>
  <tr> 
    <td><a href="infres42.html" target="_top" onClick="MM_nbGroup('down','group1','contents','',1)" onMouseOver="MM_nbGroup('over','contents','../figs/contents1.gif','',1)" onMouseOut="MM_nbGroup('out')"><img name="contents" src="../figs/contents.gif" border="0" alt="" onLoad=""></a></td>
    <td><a href="../iraindex.html" target="_top" onClick="MM_nbGroup('down','group1','authorindex','',1)" onMouseOver="MM_nbGroup('over','authorindex','../figs/iauthori1.gif','',1)" onMouseOut="MM_nbGroup('out')"><img src="../figs/iauthori.gif" alt="" name="authorindex" width="120" height="20" border="0" onload=""></a></td>
    <td><a href="../irsindex.html" target="_top" onClick="MM_nbGroup('down','group1','subjindex','',1)" onMouseOver="MM_nbGroup('over','subjindex','../figs/isubji1.gif','',1)" onMouseOut="MM_nbGroup('out')"><img src="../figs/isubji.gif" alt="" name="subjindex" width="120" height="20" border="0" onload=""></a></td>
    <td><a href="../search.html" target="_top" onClick="MM_nbGroup('down','group1','search','',1)" onMouseOver="MM_nbGroup('over','search','../figs/isearch1.gif','',1)" onMouseOut="MM_nbGroup('out')"><img src="../figs/isearch.gif" alt="" name="<span>search</span>" <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> width="120" height="20" border="0" onload=""></a></td>
    <td><a href="../index.html" target="_top" onClick="MM_nbGroup('down','group1','home','',1)" onMouseOver="MM_nbGroup('over','home','../figs/ihome1.gif','',1)" onMouseOut="MM_nbGroup('out')"><img name="home" src="../figs/ihome.gif" border="0" alt="" onLoad=""></a></td>
  </tr>
</table>
<hr color=#ff00ff size=3>

<h1>Information contracting <span>tools</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in a cancer specialist unit: the role of Healthcare Resource Groups (HRGs)</h1>


<h4>Carol Marlow</a><br>Royal Marsden Hospital, London<br><a href="MAILTO: hjp@aber.ac.uk">Hugh Preston</a><br>Department of Information and Library Studies<br>University of Wales, Aberystwyth, SY23 3AS</h4>


<div>Abstract</div>


<blockquote>The need for high <span>quality</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>management information within the contracting process has driven many of the <span>major</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>developments in health service computing. These have often merged clinical and financial requirements, usually along patient-centred <span>lines</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> In order to identify a common currency for a <span>range</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of clinical activities that are inherently variable, price tariffs have been <span>drawn</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>up on the basis of 'episodes of care' within specialties. Healthcare Resource Groups (HRGs) were <span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to meet the need for a common information currency. However, they were <span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>for acute care. The study on which this paper is based aims to examine their applicability to chronic care in a cancer specialist unit. The data were <span>drawn</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the patient information system within a <span>major</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>cancer unit. The <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of the <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>is encapsulated in the following questions: a) Do HRGs really work as a grouping and costing methodology? b) How relevant are HRG classifications for long-term patient care? The <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>demonstrated that not all HRGs are iso-resource within this <span>environment</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> The <span>findings</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the data analysis are echoed by the NHS Executive's own evaluation (<a href="#refs">NHSE, 1995</a>). This does not negate advantages in their use. <span>Furthermore</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> the development of Health Benefit Groups as information management <span>tools</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> through a <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on health conditions and interventions rather than on <span>purely</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on <span>treatments</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> <span>offers</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>potential for greater validity within a chronic care <span>situation</span>. <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>
</blockquote>
<br>

<h2>Role of Healthcare Resource Groups </h2>

<p>In order to <span>establish</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>a manageable, equable and equitable currency,
the NHS Executive has <span>attempted</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to <span>establish</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>a means of identifying
<span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>within clinically homogeneous, isoresource groups. Since
1992 it has been promoting the use of such categories for inpatient
and daycase <span>episodes</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> under the title of Healthcare Resource Groups
(HRG). The role of these was made clear in NHSE <span>statements</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>(<a href="#refs">NHSE,
1994</a>):</p>

<p>&quot;HRGs are a nationally recognised method of <span>classifying</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>casemix
by categorising patients into a manageable number of groups which
are:</p>

<ul>
<li>clinically similar (homogeneous);</li>
<li>expected to consume similar <span>amounts</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of resource (iso-resource);</li>
<li>used as a &quot;language&quot; between clinicians and managers&quot;</li>
</ul>

<p>The methods employed to develop HRGs have also been set out and
<span>indicate</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>the reliance on clinical coding standards (<a href="#refs">NHSE, 1993</a>):</p>

<p>
&quot;HRGs use ICD diagnostic <span>codes</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and OPCS procedure <span>codes</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>as
the basis of grouping, together with information on age and discharge
<span>status</span>. <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> Records can be grouped using only the Minimum Contract
Dataset information which is collected on all acute inpatient
and daycase episodes&quot;.</p>
<p>
As such, HRGs are <span>intended</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to offer a workable solution to the need for more meaningful information. They are at an <span>intermediate</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>level of <span>statistical</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>analysis coming between specialty, which contains insufficient detail about patient based workload, and diagnosis, with so much detail that the global view becomes <span>lost</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> This is shown as follows:</p>


<table bgcolor="#D2FFFF" align="center" border cellpadding="5">
<caption align="bottom"><br><div>Table 1</div></caption>
<tr><th><i>Classification</i></th><th><i>Number</i></th></tr>
<tr><td>Specialties</td><td align="right"> ~15</td></tr>
<tr><td>HRGs</td><td align="right">~500</td></tr>
<tr><td>ICD10 diagnostic codes</td><td align="right">~12000</td></tr>
</table>

<p>A comparative overview is <span>offered</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>by the NHS Executive's Information
Management Group in documentation relating to the classifications
(<a href="#refs">NHSE IMG, 1994</a>).</p>

<h2>The study: the use of HRGs in cancer care </h2>

<p>The research project forming the basis of this paper is a study
of the application of HRGs in contracting for cancer services.
This is an evaluation of their suitability as groupings within
administrative information <span>systems</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in respect of purchasers' requirements
and patients' needs. The <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of the <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>is encapsulated
in the following questions:</p>

<ul>
<li>Do HRGs really work as a grouping and costing methodology?</li>
<li>How relevant are HRG classifications for long-term patient
care?</li>
</ul>

<p>These questions arose from the managerial need to match episode
based costing of healthcare with the requirements of cancer treatment.
The concept of a hospital <span>episode</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>as a commercial commodity and
information <span>entity</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>may be appropriate for many acute medical conditions,
but chronic diseases <span>require</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>long <span>term</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>care. The management of
cancer patients involves three different treatment modalities:
surgery, chemotherapy and radiotherapy, alone or in <span>combination</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>
The duration of active treatment is variable. It can span over
many years, during which time the patient can have several admissions
to hospital; or may be treated entirely on an outpatient basis.
The <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of HRGs and their relevance to cancer care was
initiated as a result of the immediate paradox between the treatment
of chronic disease and the costing of the care. Leading on from
initial <span>findings</span>, <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> it explores the ways in which contract information
can be enhanced, either as an alternative to, or in combination
with, HRGs.</p>

<p>Collection of data for the study has taken place within a major
specialist cancer unit and examines the relevance of HRG information
for a group of cancer patients within the gynaecology specialty.
This <span>focus</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>was the result of there being no current HRGs for oncology,
so gynaecology was chosen as an instance of a grouped clinical
activity involved in cancer diagnosis and treatment. 1997/8 information
from the National Casemix Office indicates that this will continue
for the time being. The methodology involved a retrospective analysis
of patient data to <span>obtain</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>information about the care episodes
that comprise individual <span>treatments</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>for specific cancer diagnoses.
Costed patient activity data were classified within HRGs and tested
to ascertain the homogeneity of the groupings - to see whether
they are &quot;iso-resource&quot;. The data were then analysed
further, within diagnostic categories, to try and <span>establish</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>whether
any pattern, of <span>treatments</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and costs, could be discerned from
the activity records.</p>

<h3>Characteristics of the study </h3>

<p>The perceived anomalies in treatment of chronic disease and in
the costing of the care, provided the background to a problem
area that had other irregular <span>characteristics</span>. <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> The reliance of
HRG based costing formulae on <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of care, implied that these
<span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>were commonly <span>understood</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and interpreted. <span>A+</span>  <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span><span>survey</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of
1994/95 price tariffs for extra-contractual referrals (ECRs) issued
by twenty different Trusts showed that <span>charges</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>were based on episodes
of care, classified as FCEs (finished consultant episodes). These
were either within specialties, which in these instances might
include paediatrics, or for specific <span>treatments</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>eg. bone marrow
transplants. Some hospitals had additional tariffs for diagnostic
procedures, such as X-rays and blood <span>tests</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> These <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of
care are inpatient stays, daycase admissions and outpatient attendance.
Such standard measures give the impression of similarity, but
these classifications do not always imply homogeneous services.
Tariffs, for example, could be qualified by making additional
<span>charges</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>for inpatient stays exceeding 28 days, patient transport
costs, prostheses or certain high-cost drugs. The unit of an FCE
may not <span>necessarily</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>be the whole <span>period</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of an admission, as it
<span>refers</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to the part of an inpatient stay spent under the care of
an individual consultant - whose definition is not always interpreted
in a consistent manner. Even where there may be consistency in
relating admissions to consultants, the admissions themselves
may vary in the extent to which they relate to an FCE (<a href="#refs">Clarke
&amp; McKee, 1992</a>). Different hospitals have different methods
of coding this activity for contracting purposes; some count each
patient <i>visit</i> for chemotherapy or radiotherapy as a daycase
FCE while another counts a <i>course</i> of chemotherapy or radiotherapy
as an outpatient FCE (<a href="#refs">Gandy, 1996</a>)</p>
<p>
Finally, there may be differences in the classifications themselves.
<span>A+</span>  <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>patient suffering from gynaecological cancer could be categorised
within one of several specialties: general surgery, medical oncology,
radiotherapy or gynaecology - depending on their treatment and
the hospital's method of assigning diagnoses, or <span>treatments</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> to
clinical specialties. Consistency of management information is
clearly an issue in this context.</p>

<h3>Episode cost analysis </h3>

<p>
The <span>classification</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of Gynaecology HRGs is based primarily on operating
procedures, although they are split into two groups: surgical
and medical. The information that determines the classification
of admission and daycase <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>by HRG is diagnosis, procedure
and patient age. For ordinary admission <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>the <span>length</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of
stay is also relevant: data is &quot;trimmed&quot; to exclude
&quot;outliers&quot; - <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of abnormally long duration. The
NCMO guidelines include <span>statistical</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>information on average lengths
of stay, and the &quot;trim point&quot;, for each HRG (<a href="#refs">NCMO, 1994</a>).</p>
<p>
In order to <span>establish</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>the existence of relationships between HRGs
and costs, a cost analysis of eight sets of HRGs used in this
study is given in the following <span>table</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> These were the datasets
for which the information system provided a significant number
of records.</p>

<ul>
<li>Two surgical HRGs M04 and M07 - ordinary admission <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>(within &quot;normal&quot; length-of-stay limits)</li>
<li>Four medical HRGs M27, M28, M29 and M30 - ordinary admission <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>(within &quot;normal&quot; length-of-stay limits)</li>
<li>One medical HRG M29 - ordinary admission <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>(outliers) </li>
<li>One medical HRG M29 - daycase episodes</li>
</ul>
<br>

<table bgcolor="#D2FFFF" align="center" border cellpadding="5">
<caption align="bottom"><br><div>Table 2: Summary of costed HRG episodes</div></caption>
<tr><th>HRG</th><th>Episode Type</th><th>Events</th><th>Lower<br>Quartile</th><th>Median<br>Cost</th><th>Upper<br>Quartile</th></tr>
<tr><td>M29</td><td>Daycase</td><td align="right">200</td><td align="right">&#163;216</td><td align="right">&#163;271</td><td align="right">&#163;552</td></tr>
<tr><td>M04</td><td>FCE (trimmed)</td><td align="right">36</td><td align="right">&#163;1,194</td><td align="right">&#163;1,392</td><td align="right">&#163;1,600</td></tr>
<tr><td>M07</td><td>FCE (trimmed)</td><td align="right"> 22</td><td align="right">&#163;1,040</td><td align="right">&#163;1,253</td><td align="right">&#163;1,576</td></tr>
<tr><td>M28</td><td>FCE (trimmed)</td><td align="right">31</td><td align="right">&#163;272</td><td align="right">&#163;524</td><td align="right">&#163;815</td></tr>
<tr><td>M29</td><td>FCE (trimmed)</td><td align="right">380</td><td align="right">&#163;288</td><td align="right">&#163;505</td><td align="right">&#163;834</td></tr>
<tr><td>M30</td><td>FCE (trimmed)</td><td align="right">44</td><td align="right">&#163;707</td><td align="right">&#163;1,508</td><td align="right">&#163;3,420</td></tr>
<tr><td>M31</td><td>FCE (trimmed)</td><td align="right">174</td><td align="right">&#163;537</td><td align="right">&#163;791</td><td align="right">&#163;1,215</td></tr>
<tr><td>M29</td><td>FCE (outliers)</td><td align="right">50</td><td align="right">&#163;2,589</td><td align="right">&#163;3,863</td><td align="right">&#163;5,740</td></tr>
</table>
               
<p>It should be noted that the prices for this exercise are estimates
as a tool for the research. They are <i>comparative</i> rather
than absolute and have no bearing on any <span>actual</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>costs within a
particular cancer unit.</p>

<p>The data records relating to these eight HRGs were then studied
to try to arrive at an answer to the question &quot;do HRGs work,
as a costing methodology?&quot;. The costed <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>within each
HRG were analysed to see whether:</p>

<ul>
<li>- each group was homogeneous, i.e. similar in terms of cost (iso-resource);</li>
<li>- individual groups could be separately identified (by their cost ranges or mean values);</li>
<li>- costs are related to HRG categories, i.e. to determine whether a HRG category might be a reasonably <span>accurate</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>predictor of the likely cost of an <span>episode</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></li>
</ul>

<p>From the <span>table</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>we can see that two pairs of HRGs for trimmed ordinary
admissions appear to be very similar:</p>


<ul>
<li>M04 Minor procedures uterus/adnexae &amp; M07 Intermediate procedures cervix/uterus
<li>M28 Carcinoma of ovary aged &gt; 69 or with complications &amp; M29 Carcinoma of ovary aged &lt; 70 without complications
</ul>

<p>
and that M04/M07, M28/M29 and M31 appear to be discrete sets,
distinguishable by their different median <span>values</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>while at the
same time having comparable inter-quartile ranges.</p>
<p>
The <span>table</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>also highlights the wide ranges between the upper and
lower quartiles for M30 (other gynaecological malignancy aged
&gt; 64 or with complications), trimmed ordinary admissions and
M29 outliers (those whose admission lasted longer than six nights)
- and the <span>con0erable</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>contrast between the cheapest (M29 daycases)
and most expensive (M29 outliers) groups.</p>
<p>
The 937 data records were analysed using Minitab <span>software</span>. <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> Parametric
<span>tests</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>such as analysis of variance and T-Tests (to decide whether
there is a significant difference between the mean costs of two
populations) <span>assume</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>a normal <span>distribution</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> Had the data been plotted
on a graph, with cost <span>values</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>(grouped into cost bands) along the
x axis and number of <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in each cost band on the y axis,
this would have shown a non-normal <span>distribution</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> that is, positively
skewed. For this reason it was more appropriate to use non-parametric
<span>tests</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on the data sets.</p>

<h4>Kruskal-Wallis <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></h4>

<p>The purpose of this <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>was to <span>establish</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>whether or not each
set of HRG data records are different from each other. HRGs are
<span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to be homogeneous in respect of their clinical classifications,
but unless there is also some difference in terms of cost then
the point of having so many different groupings within the same
specialty would be questionable.</p>

<p>The results of the Kruskal-Wallis <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>are reproduced in the following table:</p>


<table bgcolor="#D2FFFF" align="center" border cellpadding="5">
<caption align="bottom"><br><div>Table 3: Costed HRG episodes: Kruskal-Wallis test</div></caption>
<tr><th>HRG</th><th>Episode Type</th><th>No. of <br>Observations</th><th>Median<br>Cost</th><th>Average<br>Rank</th><th>Z Value</th></tr>
<tr><td>M04</td><td>FCE (trimmed)</td><td align="center">36</td><td align="right">&#163;1,392.2</td><td align="right">757.0</td><td align="right">6.51</td></tr>
<tr><td>M07 </td><td>FCE (trimmed)</td><td align="center">22</td><td align="right">&#163;1,253.2</td><td align="right">720.6</td><td align="right">4.41</td></tr>
<tr><td>M28</td><td>FCE (trimmed)</td><td align="center">31</td><td align="right">&#163;523.6</td><td align="right">409.4</td><td align="right">-1.25 </td></tr>
<tr><td>M29</td><td>FCE (trimmed)</td><td align="center">380</td><td align="right">&#163;505.4</td><td align="right">415.5</td><td align="right">-5.00</td></tr>
<tr><td>M30 </td><td>FCE (trimmed)</td><td align="center">44</td><td align="right">&#163;1,507.9</td><td align="right">711.5</td><td align="right">6.09</td></tr>
<tr><td>M31</td><td>FCE (trimmed)</td><td align="center">174</td><td align="right">&#163;790.6</td><td align="right">568.7</td><td align="right">5.39</td></tr>
<tr><td>M29</td><td>Daycases</td><td align="center">200</td><td align="right">&#163;271.1</td><td align="right">254.7</td><td align="right">-12.63</td></tr>
<tr><td>M29</td><td>FCE (outliers)</td><td align="center">50</td><td align="right">&#163;3,863.2</td><td align="right">891.5</td><td align="right">11.35</td></tr>
<tr><td>OVERALL</td><td>&nbsp;</td><td align="center">937</td><td align="right">&nbsp;</td><td align="right">469.0</td><td align="right">&nbsp;</td></tr>
</table>

<p>The &quot;Z value&quot; is the distance from the mean rank of
the whole data set (937 records) in <span>comparison</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>with the mean rank
of each group within it. The null hypothesis, that there is little
difference between each set, would yield a Z value of <span>zero</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> The
result shows that all <span>values</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>except M28 are significantly different
from the mean rank (that is, having a Z value greater than two
or less than minus two). This may not be surprising since each
of the sets excludes the outliers and the daycases, the longer
than average stays and the shortest stays - but they have been
included in the <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>as <span>separate</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>groups. To see just how much
the results are affected by these two groups the <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>was repeated
- excluding the outliers and daycases:</p>

<table bgcolor="#D2FFFF" align="center" border cellpadding="5">
<caption align="bottom"><br><div>Table 4: Costed HRG episodes: Kruskal-Wallis <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>on trimmed FCEs</div></caption>
<tr><th>HRG</th><th>Episode Type</th><th>No. of <br>Observations</th><th>Median<br>Cost</th><th>Average<br>Rank</th><th>Z Value</th></tr>
<tr><td>M04</td><td>FCE (trimmed)</td><td align="center">36</td><td align="right">&#163;1,392.2</td><td align="right">558.6</td><td align="right">6.67</td></tr>
<tr><td>M07</td><td>FCE (trimmed)</td><td align="center">22</td><td align="right">&#163;1,253.2</td><td align="right">523.0</td><td align="right">4.30</td></tr>
<tr><td>M28</td><td>FCE (trimmed)</td><td align="center">31 </td><td align="right">&#163;523.6</td><td align="right">271.3</td><td align="right">-2.09</td></tr>
<tr><td>M29</td><td>FCE (trimmed)</td><td align="center">380</td><td align="right">&#163;505.4</td><td align="right">275.1</td><td align="right">-10.12</td></tr>
<tr><td>M30</td><td>FCE (trimmed)</td><td align="center">44 </td><td align="right">&#163;1,507.9</td><td align="right">513.8</td><td align="right">5.86</td></tr>
<tr><td>M31</td><td>FCE (trimmed)</td><td align="center">174</td><td align="right">&#163;790.6</td><td align="right">397.4</td><td align="right">4.11</td></tr>
<tr><td>OVERALL</td><td>&nbsp;</td><td align="center">687 </td><td align="right">&nbsp;</td><td align="right">344.0</td><td align="right">&nbsp;</td></tr>
</table>

 
<p>This time, <i>all</i> the Z <span>values</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>were significantly different
from the mean rank. The Z <span>values</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>show where differences <span>arise</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>
which leads on to the next <span>test</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></p>

<h4>Mann-Whitney <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></h4>

<p>This <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>compares the medians of two populations, the null hypothesis being that they have distributions which are <span>identical</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in all respects. For this <span>test</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>four pairs of HRGs were selected, on the
basis that they have logical links:</p>

<table bgcolor="#D2FFFF" align="center" border cellpadding="5">
<caption align="bottom"><br><div>Table 5: HRG pairs for Mann-Whitney test</div></caption>
<tr><td>M04 and M07</td><td>the two surgical groups</td></tr>
<tr><td>M28 and M29</td><td>Ca. ovary: medical patients aged &gt; 69<br>  
compared with those aged &lt; 70</td></tr>
<tr><td>M30 and M31</td><td>other gynaecological malignancy:<br>       
medical patients aged &gt; 64 compared<br>    
with those aged &lt; 65</td></tr>
<tr><td>M29 (trimmed) <br>and M29 (outliers)</td><td>Ca. ovary: medical patients aged &lt;<br>     
70, those who stayed for a maximum of <br> 
6 nights compared with those who<br>       
stayed longer  </td></tr>
</table>

<p>The results of these <span>tests</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>confirmed the original indications
from the Kruskal-Wallis <span>test</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> There was no significant difference
between the two surgical groups M04 and M07. And although there
was no difference between the two groups with Ca. ovary, M28 and
M29, there was a very clear difference between the trimmed M29
<span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and the outliers. Also the groups of patients with &quot;other
gynaecological malignancies&quot;, M30 and M31, were found to
differ.</p>

<h3>Data analysis</h3>

<p>Of the data sets analysed in this study, some results were much
as anticipated while some of the <span>findings</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>were somewhat ambiguous.
Any conclusions <span>drawn</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the results of the investigations are
<span>limited</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> because of the omission of radiotherapy and chemotherapy
expenditure in calculating the <span>episode</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>costs of the medical HRGs.</p>

<p>Two pairs of groups <span>appeared</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to be similar in terms of cost: M04
and M07, M28 and M29, despite the differences in their trim points.
Although group M04 comprises minor surgical procedures while M07
is a group of <span>intermediate</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>procedures, the average duration of
the admissions were very similar and there was no significant
difference between their <span>episode</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>costs. For M04 the trim point
is 3 nights, 6 nights for M07. The records show that 4 nights
was the maximum duration for the 22 patients whose admission coded
to M07. Both groups had a very similar average <span>length</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of stay
- in fact M04 were slightly longer with an average of 2.19 nights
while M07 averaged 2.05 nights.</p>

<p>Comparing groups M28 and M29 shows the same picture: they are
not significantly different. Although it would seem that the older
patients are <span>expected</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to tend to stay longer (the trim point for
M28 is 23 nights, but it is only 6 nights for the younger patients,
M29), in fact the average duration for both groups was virtually
the same: 1.77 nights for M28 and 1.76 nights for M29. For the
<span>sample</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>patients, then, it seems <span>reasonable</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to <span>assume</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>that the
patients' ages did not influence their lengths of stay and, it
follows, the median cost of these <span>episodes</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></p>

<p>Therefore, for this study group, it appears that the two pairs
of groups that looked similar really do seem to be comparable
in terms of both cost and duration of admission. What is surprising
then is that these HRGs (M04/M07 and M28/M29) are <span>separate</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>classifications.
This would seem to imply that there <i>ought</i> to have been
differences in these groups, in their lengths of stay (and episode
costs).</p>

<p>The largest group in the dataset was the trimmed M29 <span>episodes</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>
that is, patients aged below 70 with carcinoma of ovary, excluding
outliers. There were 380 of these events. The <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>related
to 145 patients, all but one of whom had an ICD9 code of 183.0
(malignant neoplasm ovary), the single exception having a diagnosis
of metastatic adenocarcinoma of ovary, ICD9 code 198.6.</p>
<p>
For ovarian cancer the standard treatment, for patients with operable
disease, is total hysterectomy, salpingo-oophorectomy and omentectomy
- surgical <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>which would have derived a HRG code of M11
&quot;Major procedures of uterus/adnexae&quot;. Where the disease
is more <span>advanced</span>, <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> but still localised to the abdominopelvic cavity,
surgery is <span>followed</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>by platinum based chemotherapy (Neal &amp;
Hoskin, 1994). In patients whose disease is beyond all hope of
cure, radiotherapy may be given for symptom palliation. Eight
of the patients in the study group received radiotherapy, four
of these women were given no other form of treatment at the unit.</p>
<p>
Excluding the cost of drugs and radiotherapy, all the medical
<span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>that were coded to HRG M29 have a median cost of &#163;505
and average cost of &#163;644. The cost at the upper quartile
was &#163;834, &#163;329 (65%) more than the median and &#163;190
(30%) more than the mean. The cost of the most expensive episode
in this group was &#163;2,925 which is almost six times greater
than the median value. Even this group, with all its similarities
in diagnoses and narrow <span>range</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of admission durations (maximum
duration of stay being six nights), had quite widely varying episode
costs. It seems <span>reasonable</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to <span>assume</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>that if treatment costs had
been included in the <span>episode</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>prices this additional cost variable
would have led to even more differences in price.</p>
<p>
For the same group of patients, HRG M29, there was a clear difference
between the trimmed admission <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and the outliers. We know
that the <span>episode</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>costs are largely determined by the duration
of the admission, particularly for the medical groups where treatment
costs are excluded from the data. So it was no surprise to find
that the outliers, who all stayed in excess of six nights, were
found to have a much higher median value (i.e. were dearer) than
the trimmed data: patients who stayed a maximum of six nights.</p>
<p>
For the M29 outliers the minimum <span>length</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of stay was <span>seven</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>nights
and there was no maximum set (in fact the average number of beddays
was 15, the longest duration was for a patient who stayed 44 nights).
This was the dearest group in the study, with the greatest inter-quartile
<span>range</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></p>
<p>
As anticipated, M29 daycases were clearly much cheaper than other
groups. The evidence for this is provided by the <span>table</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and the
Kruskal-Wallis <span>test</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> This group had the smallest inter-quartile
<span>range</span>, <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> which was doubtless due to the <span>parity</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in lengths of stay:
all patients were admitted and discharged on the same <span>day</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></p>
<p>
As has been stated, both the groups with carcinoma of ovary, M28
and M29, were not significantly different, however it appears
that age <i>could</i> affect <span>episode</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>costs for &quot;other gynaecological
malignancies&quot;: these two groups, M30 and M31, were found
to be different. This is not unexpected, con0ering the differences
in trim points - although it might potentially have been caused
by differences in casemix.</p>
<p>
Of the 174 <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in M31, 159 (91%) were for Ca. cervix. The
<span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in this group had a median cost of &#163;791, but the
trim point is only 13 nights and the average <span>length</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of stay was
3 nights.</p>
<p>
The median cost of M30 <span>episodes</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> with a trim point of 40 nights,
was &#163;1,508. The average <span>length</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of stay for the M30 group
was, in fact, 10 nights with durations of admission ranging between
1 night and 37 nights. The <span>variation</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in lengths of stay also explains
the large disparity between the lower and upper quartiles for
the <span>episode</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>costs of this group. M30 comprised 44 <span>episodes</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> of
which 11 were for patients with cancer of the vulva and had an
average duration of 17 nights. 31 <span>episodes</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>related to Ca. cervix,
but even they had, on average, a longer stay than the women in
the younger age group with the same diagnosis: 8 nights.</p>

<h3>Discussion of findings</h3>

<p>
<span>Statistical</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>measures of correlation applied to the historical
data provide some guidance in attempting to answer the two questions
relating to the value and relevance of HRGs. As management information
<span>tools</span>, <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> they need to offer <span>sufficient</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>uniformity as a currency
to act as identifiable <span>units</span>. <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> In addressing the original questions
behind the study, the <span>findings</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span><span>indicate</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>the following.</p>
<p>
<i>Do HRGs really &quot;work&quot; - as a grouping and costing
methodology?</i> </p>
<p>
The <span>investigation</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>demonstrated that not all HRGs are iso-resource.
The <span>findings</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>from the data analysis are echoed by the NHSE's own
evaluation (<a href="#refs">NHSE, 1995</a>). This does not negate advantages in their
use. In some cases HRGs were found to be isoresource by one measure.
An example of this is the correlation between cost and length
of stay. An additional analysis took place of the costs of ordinary
admissions plotted against their beddays. The correlation found
between these two variables, 0.95 in the data set, confirms their
close relationship, even though the surgical HRGs included treatment
costs while the medical HRGs did not. Consequently, the longer
the duration of the admission the greater the cost of the <span>episode</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span></p>
<p>
<i>How relevant are HRG classifications for long-term patient
care?</i> </p>
<p>
This cannot be answered fully just yet. The gynaecology HRGs analysed
in this study would be adequate for surgical <span>episodes</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> but this
may only <span>reflect</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>a single stage of the overall treatment strategy.
In respect of medical <span>treatments</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>for cancer patients HRGs give
no clinical information and, in this study, no indication of the
cost of the treatment element. HRGs <span>devised</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>specially for oncology
would be <span>designed</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to overcome these failings. Current development
of Health Benefit Groups (HBGs) may <span>hold</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>the answer through better
understanding of outcomes and the <span>actual</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>benefits of healthcare.
These are an example of various techniques for measuring casemix
that are currently being researched, such as Patient Management
Categories, Resource Utilisation Groups and HBGs themselves. They
are <span>intended</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to enable a better understanding of outcomes, and
to <span>reflect</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>the benefits of care. HBGs will &quot;provide an invaluable
tool for strategic commissioning and contracting for health benefit,
as well as enhancing the use of HRGs by linking health need to
costed patient care&quot; (<a href="#refs">NCMO, 1995</a>). HBGs will be additionally
valuable as information <span>tools</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>through their <span>mapping</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>to ICD codes
and HRGs (<a href="#refs">NCMO, 1996a</a>).</p>
<p>
HBGs should be particularly appropriate in the cancer <span>setting</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>
While HRGs are primarily concerned with <span>treatments</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and take no
account of the severity of a patient's illness, HBGs are based
on the <span>condition</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and the level of severity within that <span>condition</span>, <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>
with the aim of determining the appropriate treatment and predicting
the likely outcome. &quot;HBGs are linked with appropriate HRGs
in a matrix to enable the resource requirements of a population
to be <span>measured</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and the likely benefits identified&quot; (<a href="#refs">NCMO,
1996b</a>). This system should increase the clinical relevance of
contract management information. Even if it does not entirely
succeed it still <span>offers</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span><span>con0erable</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>benefits, particularly to
purchasers. It promises a <span>combination</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of <span>qualitative</span>  <span class="quali" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>information,
the clinical <span>details</span>, <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> with the quantitative information necessary
for contract management. HBGs provide information on resources
linked to people rather than <span>treatments</span>. <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> They should enable <i>prediction</i>
of treatment and link this to outcomes. This capability is not
a <span>feature</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>of HRGs although version 3 of the groupings, released
in September 1997 may, with further analysis, <span>prove</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>more effective
(<a href="#refs">NCMO, 1997</a>).</p>

<h2><a name="refs"></a>References</h3>
<ul>
<li>Clarke, <span>A+</span>. <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> &amp; McKee, M. (1992) &quot;The consultant episode: an unhelpful measure.&quot; <i>British Medical Journal</i>, <b>305</b>, 1307-8
<li>Gandy, <span>R++</span>. <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> (1996) &quot;Clinical coding and cancer care.&quot; <i>British Journal of Healthcare <span>Computing</span>  <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>and Information Management</i>, <b>13</b> (4).
<li>NCMO. (1994) <i>Healthcare Resource Groups Version 1.2 Introduction and Guidance</i>. Winchester: NCMO.
<li>NCMO. (1995) <i>The national casemix office of the information management group - Project progress report. Issue 6</i>. Winchester: NCMO.
<li>NCMO. (1996a) <i>Health Benefit Groups <span>Development</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>Project: information sheet</i>, Winchester: NCMO.
<li>NCMO. (1996b) <i>The national casemix office of the information management group - Project progress report. Issue 10</i>. Winchester: NCMO.
<li>NCMO. (1997) <i>Version 3 HRG documentation set - compendium</i>. Winchester: NCMO.
<li>Neal, <span>A+</span>. <span class="compus" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span> &amp; Hoskin, P. (1994)<i> <span>Clinical</span>  <span class="exper" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>oncology: a <span>textbook</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>for students</i>. London: Edward Arnold.
<li>NHSE. (1993) <i>Healthcare resource group version 2 consultation <span>documents</span>  <span class="quanti" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>EL(93)91</i>. Leeds: NHSE.
<li>NHSE. (1994) <i>Costing for Contracting Manual: Acute Services FDL(94)46</i>. Leeds: NHSE.
<li>For example, <i>NHSE IMG. (1994) ICD-10</i>, Leeds: NHSE IMG.
<li>NHSE. (1995)<i> Costing for contracting. Costed HRGs - evaluation summary report</i>. Leeds: NHSE.
</ul>
<hr color=#ff00ff size=3>
<p style="text-align : center; color : Red; font-weight : bold;">How to cite this paper:</i></p>
<p style="text-align : left; color : black;">Marlow, Carol &amp; Preston, Hugh (1998)&nbsp; &quot;Information contracting <span>tools</span>  <span class="conce" style="width:1px;border-width:75px 25px 75px 25px;position:relative;">.</span>in a cancer specialist unit&quot;&nbsp;&nbsp;<em>Information Research</em>, <strong>4</strong>(2) Available at: http://informationr.net/ir/4-2/paper52.html</p>
<p style="text-align : center"> the authors, 1998. Last updated: 22nd September 1998</p>
<hr color=#ff00ff size=3>
<table border="0" cellpadding="15" cellspacing="0" align="center">
<tr> 
    <td><a href="infres42.html"><h4>Contents</h4></a></td>
   <td align="center" valign="top"><div>
<img src="http://counter.digits.com/wc/-d/-z/6/-b/FF0033/paper52" align="middle"  width="60" height="20" border="0" hspace="4" vspace="2" alt="counter" /><br /><a href="http://www.digits.com/">Web Counter</a>
</div></td>
    <td><a href="../index.html"><h4>Home</h4></a></td>
  </tr>
</table>
<hr color=#ff00ff size=3>

<script src="http://www.google-analytics.com/urchin.js" type="text/javascript">
</script>
<script type="text/javascript">
_uacct = "UA-672528-1";
urchinTracker();
</script>
</body>


<!-- Mirrored from informationr.net/ir/4-2/paper52.html by HTTrack Website Copier/3.x [XR&CO'2010], Sat, 25 Dec 2010 19:19:22 GMT -->
</html>
